NorthStar’s RadioGenix system produces the medical radioisope Mo-99 without the use of uranium. (Photo: NorthStar)
NorthStar Medical Technologies of Beloit, Wis., will receive $37 million under two cooperative agreements with the National Nuclear Security Administration for the production of molybdenum-99 without the use of high-enriched uranium. Considered a critical medical radioisotope, Mo-99 is used in more than 40,000 medical procedures in the United States each day, including the diagnosis of heart disease and cancer.
The closed Vermont Yankee power plant is currently undergoing decommissioning. (Photo: Entergy)
The Nuclear Regulatory Commission is set to allow about 2 million gallons of low-level radioactive wastewater from the Vermont Yankee nuclear power plant, currently undergoing decommissioning, to be disposed of at an Idaho waste facility. As published in the May 7 Federal Register, the NRC has issued an environmental assessment and finding of no significant impact for a request by NorthStar Nuclear Decommissioning to dispose of the wastewater at US Ecology Idaho’s waste facility near Grand View.
NorthStar is capable of producing Mo-99 using non-uranium-based processes. Photo: NorthStar Medical Radioisotopes
Completing a 5,700-mile journey from Belgium, two 24-ton particle accelerators were delivered to NorthStar Medical Radioisotopes’ facility in Beloit, Wis., on April 22, the Wisconsin State Journal reported. Photos and a video of the accelerators being received at the facility are included in the report.